KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) EPS (Weighted Average and Diluted) (2016 - 2025)

Repligen (RGEN) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $0.23 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 137.7% to $0.23 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.86, a 286.96% increase, with the full-year FY2025 number at $0.86, up 286.96% from a year prior.
  • EPS (Weighted Average and Diluted) was $0.23 for Q4 2025 at Repligen, down from $0.26 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.88 in Q2 2022 to a low of -$0.61 in Q4 2024.
  • A 5-year average of $0.31 and a median of $0.27 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 132.94% in 2023, then skyrocketed 2700.0% in 2025.
  • Repligen's EPS (Weighted Average and Diluted) stood at $0.5 in 2021, then soared by 70.0% to $0.85 in 2022, then tumbled by 132.94% to -$0.28 in 2023, then plummeted by 117.86% to -$0.61 in 2024, then surged by 137.7% to $0.23 in 2025.
  • Per Business Quant, the three most recent readings for RGEN's EPS (Weighted Average and Diluted) are $0.23 (Q4 2025), $0.26 (Q3 2025), and $0.27 (Q2 2025).